Care conundrum

A growing tide is reshaping private healthcare—one that blends expansion with scrutiny, innovation with accountability. Big wins like Almac’s £1bn milestone and Quasar’s cross-border growth signal confidence in the sector’s commercial strength. But that same momentum exposes deeper tensions. Auditors face growing pressure in the wake of corporate collapses. Private equity's stake in cardiology sparks concern over care quality. And while digital health offers new hope for complex conditions, it also raises new questions about access and implementation. 

At the heart of it all, leadership grounded in compassion may be the only constant. The challenge now is balancing rapid growth with responsibility—and remembering that care must always come first.